Participant flow14

How many started, completed or left each group, period by period.

1 to 14 of 14

Period	Milestone	Group	Participants
Overall Study	STARTED	Delafloxacin	134
Overall Study	STARTED	Best Available Therapy	132
Overall Study	Vancomycin IV	Delafloxacin	0
Overall Study	Vancomycin IV	Best Available Therapy	2
Overall Study	Linezolid IV, With the Option to Switch to Linezolid Oral	Delafloxacin	0
Overall Study	Linezolid IV, With the Option to Switch to Linezolid Oral	Best Available Therapy	8
Overall Study	Piperacillin/Tazobactam IV	Delafloxacin	0
Overall Study	Piperacillin/Tazobactam IV	Best Available Therapy	68
Overall Study	Tigecycline IV	Delafloxacin	0
Overall Study	Tigecycline IV	Best Available Therapy	54
Overall Study	COMPLETED	Delafloxacin	127
Overall Study	COMPLETED	Best Available Therapy	127
Overall Study	NOT COMPLETED	Delafloxacin	7
Overall Study	NOT COMPLETED	Best Available Therapy	5

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04042077/flow